Skip to main navigation
Contact Us
Careers
Company
Leadership
Board of Directors
Science
Technology
Pipeline
Manufacturing
Therapeutic Areas
Medical Professionals
Product
Vyjuvek
Patients
Patient Resources
Investors
Contact Us
Investors
Investor Relations
Overview
News Releases
Events
Stock Information
SEC Filings
Corporate Governance
Scientific Publications
Email Alerts
Analyst Coverage
Investor FAQs
KB301 Phase 1 POC Efficacy Data Webcast
March 22, 2022 at 8:00 AM EDT
Click here for webcast